Caligor Rx strengthens its European Team
pharmafile | December 3, 2010 | Appointment | Research and Development |Â Â Caligor Rx, Jacquelyn May, Jess McKenna, appointment, research and developmentÂ
Clinical trial procurement firm Caligor Rx has appointed Jess McKenna head of quality assurance and customer relationships and Jacquelyn May head of clinical trial supplies.
In their respective roles they will be responsible for quality management systems and global comparator drug sourcing.
Jess was most recently responsible for building a quality assurance department at a leading supplier of comparator drugs and is experienced with ISO 9001 certification. Her background also includes responsibility for patient affairs at The Royal Marsden NHS Trust.
Jacquelyn May was a registered nurse for 25 years and worked for many years at the Whipps Cross University Hospital in London, England. She joins Caligor Rx after five years of experience in comparator procurement for worldwide clinical trials. Jacquelyn previously worked as a senior manager in the NHS specialising in the delivery of the Patient Advice and Liaison Service.
Jess and Jacquelyn join Caligor Rx as a team, having spent five years working together for a UK-based supplier of clinical trial supplies.
Caligor Rx’s director of sales and marketing Tammy Bishop said: “Both Ms McKenna and Ms May are highly skilled executives with significant experience in navigating the regulatory and operational complexities of comparator procurement for worldwide clinical trials.
“They both share our vision of quality, ethics, and dedication to clients; we are delighted to welcome them to our organisation, knowing their industry expertise will provide invaluable benefits to our customer worldwide.”
Related Content
PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …
AAX Biotech announces collaboration for cardiovascular antibody therapy
Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …
Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months
TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the …
